Yahoo Finance Video
Ozempic, a GLP-1 drug, has gained popularity for aiding in weight loss. Oprah Winfrey, who is on the board of WW International (WW), formerly Weight Watchers, declined to use Ozempic when it was suggested to her before knee surgery, expressing her belief that taking the medication was "the easy way out." Given Oprah's influential position, her remarks carry potential influence over people's perceptions. Interestingly, Weight Watchers has shown interest in entering the GLP-1 industry. In today's top stories, Yahoo Finance's reporter Anjalee Khemlani, Pras Subramanian, and Josh Schafer explore the future of GLP-1 drugs and whether the industry's current challenges may impact their continued relevance. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.